Yaz News
Yaz and Yasmin Legal Claims Cost Bayer $1.5 Billion
Bayer’s pharmaceutical division earnings declined by 43.3 percent in 2012, largely because of more than $1.5 billion in reserves set aside for legal claims over the oral contraceptives Yaz, Yasmin and their generic counterpart Ocella. In April 2012, the U.S. Food and Drug Administration (FDA) alerted consumers that the synthetic hormone drospirenone, the active ingredient [...]
Birth Control Pills Increase Blood Clot Risk in Women with PCOS
A new study in the Canadian Medical Association Journal found that women with polycystic ovarian syndrome (PCOS) have twice the risk of developing a blood clot when taking oral birth control. One of the study researchers, Dr. Christopher McCartney, told Reuters: “For some women, [the risks] might be high enough to say we really shouldn’t [...]
Doctors Want Birth Control Pills Sold over the Counter, but Is That Dangerous?
In its haste to make oral contraceptives more widely available in the United States, the leading women’s health care professional organization may be compromising the safety of women. The American Congress of Obstetricians and Gynecologists (ACOG) recently recommended that birth control pills be sold over the counter, meaning no prescription would be required to purchase [...]
Amid Mounting Yaz/Yasmin Lawsuits, Bayer Seeks to Diversify
In a calculated move, Bayer, the maker of Yaz/Yasmin birth control pills, purchased Schiff Nutrition International for $1.2 billion this week, making an investment in the low-risk non-prescription drug industry. Bayer also reported an 18 percent decline in net income for the third quarter, as it deals with mounting litigation over Yaz. The drugmaker has [...]
Bayer Pays $402 Million to Settle Yaz and Yasmin Lawsuits
Lawsuits stemming from blood clots linked to birth-control pills Yasmin and Yaz have been settled by Bayer AG for more than $402 million to date, the company reported in a July 31, 2012, stockholders’ newsletter. The $402.6 million price tag is the result of settling about 1,900 cases in one category of clot cases, Bloomberg [...]
Judge Extends Yaz Lawsuit Deadlines to Allow More Settlements
A judge overseeing the multidistrict litigation (MDL) regarding the oral contraceptive Yaz has cleared the way for more settlement negotiations to continue. Chief Judge David R. Herndon, of the U.S. District Court for the Southern District of Illinois, moved back the deadlines for Yaz lawsuits, allowing for the drug’s maker, Bayer, and attorneys to negotiate [...]